United States· US:72189-402_4c4baadf-895a-bd8e-e063-6294a90ad228
Phenergan
A promethazine product containing promethazine hydrochloride, registered in United States by Direct_Rx. The same ATC class is registered in 14 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Promethazine is registered in 14 of 19 countries.
Countries holding a registration under ATC R06AD02 (promethazine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 7 of them publish a price we can compare per daily dose
Promethazine · ATC R06AD02
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- PROMETHAZINE HYDROCHLORIDE
- Manufacturer
- Direct_Rx
- Country
- United States (US)
- ATC code
- R06AD02
- ATC class
- Promethazine
- Defined daily dose
- 25 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc11721894021010 TABLET in 1 BOTTLE (72189-402-10)
- ndc11721894021212 TABLET in 1 BOTTLE (72189-402-12)
- ndc11721894023030 TABLET in 1 BOTTLE (72189-402-30)
- ndc1172189-402-10
- ndc1172189-402-12
- ndc1172189-402-30
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
976 interactions on record for promethazine.
Graded by severity as the source publishes them — 87 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Promethazine · interactions on record
976 records
- 87 severe
- 625 moderate
- 19 minor
- 245 info
Most severe, free to view
- MetoclopramideA03FA01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- Potassium chlorideA12BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Promethazine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomPhenergan 10mg tabletsOpella Healthcare UK Ltd
- GermanyAtosilDesitin Arzneimittel Gmbh
- NetherlandsPromethazine ACE 25 mg/ml, oplossing voor injectieACE Pharmaceuticals B.V.
- SwedenFarghess 25 mg Filmdragerad tablettOmet Pharma AB
- Japanプロメタジン塩酸塩高田製薬
- NorwayPhenerganOpella Healthcare France SAS
- PolandDipherganBausch Health Ireland Ltd.
- FrancePHENERGAN 2 %, crèmeLABORATOIRES FRILAB
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Bulgaria · Aнтиалeрзин
- Cyprus · Promethazine Remedica
- Czechia · Prothazin
- Germany · Atosil, Atosil N
- Denmark · Phenergan, Prometazin Actavis
- Spain · Fenergan
- France · Phenergan
- United Kingdom (Northern Ireland) · Phenergan, Phenergan Elixir
- Greece · Fenimezyl, Prugal-Derm
- Hungary · Pipolphen
- Ireland · Phenergan
- Iceland · Phenergan, Prometazin Actavis
- Italy · Alontan Antistaminico, Fadezin
- Malta · Fenazil, Promethazine Remedica
- Netherlands · Promethazine Ace, Promethazine Cf
- Norway · Phenergan
- Poland · Diphergan, Polfergan
- Portugal · Prometazina Basi, Prometazina Medlink
- Sweden · Farghess, Lergigan
- Slovakia · Prothazin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/19781f14-66ca-4d41-a0b2-b8b650d34bfa GET /v1/drugs/19781f14-66ca-4d41-a0b2-b8b650d34bfa?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "12.5",
"substance": "PROMETHAZINE HYDROCHLORIDE",
"productndc": "72189-402",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA040596",
"marketing_category": "ANDA"
}See everything about promethazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.